-
1
-
-
33947526659
-
Outcomes validity and reliability of the modified rankin scale: Implications for stroke clinical trials: A literature review and synthesis
-
Banks, J.L., & Marotta, C.A. (2007). Outcomes validity and reliability of the modified rankin scale: Implications for stroke clinical trials: A literature review and synthesis. Stroke, 38(3), 1091-1096
-
(2007)
Stroke
, vol.38
, Issue.3
, pp. 1091-1096
-
-
Banks, J.L.1
Marotta, C.A.2
-
2
-
-
84859430317
-
Statistical analysis of the primary outcome in acute stroke trials
-
Bath, P.M., Lees, K.R., Schellinger, P.D., Altman, H., Bland, M., Hogg, C., et al. (2012). Statistical analysis of the primary outcome in acute stroke trials. Stroke, 43(4), 1171-1178
-
(2012)
Stroke
, vol.43
, Issue.4
, pp. 1171-1178
-
-
Bath, P.M.1
Lees, K.R.2
Schellinger, P.D.3
Altman, H.4
Bland, M.5
Hogg, C.6
-
3
-
-
84920812986
-
Evaluation of differences in brain neurophysiology and morphometry associated with hand function in indivaduals with chronic stroke
-
Borich, M.R., Neva, J.L., & Boyd, L.A. (2015). Evaluation of differences in brain neurophysiology and morphometry associated with hand function in indivaduals with chronic stroke. Restor Neurol Neurosci, 33(1), 31-42
-
(2015)
Restor Neurol Neurosci
, vol.33
, Issue.1
, pp. 31-42
-
-
Borich, M.R.1
Neva, J.L.2
Boyd, L.A.3
-
4
-
-
0034119091
-
Outcome measures in acute stroke trials: A systematic review and some recommendations to improve practice
-
Duncan, P.W., Jorgensen, H.S., & Wade, D.T. (2000). Outcome measures in acute stroke trials: A systematic review and some recommendations to improve practice. Stroke, 31(6), 1429-1438
-
(2000)
Stroke
, vol.31
, Issue.6
, pp. 1429-1438
-
-
Duncan, P.W.1
Jorgensen, H.S.2
Wade, D.T.3
-
5
-
-
34548233214
-
Hemorrhage after thrombolytic therapy for stroke: The clinically relevant number need to harm
-
Jeffrey, L., Saver. (2007). Hemorrhage after thrombolytic therapy for stroke: The clinically relevant number need to harm. Stroke, 38(8), 2279-2283
-
(2007)
Stroke
, vol.38
, Issue.8
, pp. 2279-2283
-
-
Jeffrey, L.1
Saver2
-
6
-
-
33744973270
-
Clinical interpretation and use of stroke scales
-
Kasner, S.E. (2006). Clinical interpretation and use of stroke scales. Lancet Neurol, 5(7), 603-612
-
(2006)
Lancet Neurol
, vol.5
, Issue.7
, pp. 603-612
-
-
Kasner, S.E.1
-
7
-
-
7444247486
-
Determinants of discharge destination for stroke patients
-
Lutz, B.J. (2004). Determinants of discharge destination for stroke patients. Rehabil Nurs, 29(5), 154-163
-
(2004)
Rehabil Nurs
, vol.29
, Issue.5
, pp. 154-163
-
-
Lutz, B.J.1
-
8
-
-
84879935685
-
Comparison of short-term outcomes of thrombolysis for in-hospital stroke and out-of-hospital stroke in United States
-
Moradiya, Y., & Levine, S.R. (2013). Comparison of short-term outcomes of thrombolysis for in-hospital stroke and out-of-hospital stroke in united states. Stroke, 44(7), 1903-1908
-
(2013)
Stroke
, vol.44
, Issue.7
, pp. 1903-1908
-
-
Moradiya, Y.1
Levine, S.R.2
-
9
-
-
0028783948
-
Tissue plasminogen activator for acute ischemic stroke
-
NINDS rt-PA Stroke Group
-
NINDS rt-PA Stroke Group (1995). Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine, 333(24), 1581-1587
-
(1995)
New England Journal of Medicine
, vol.333
, Issue.24
, pp. 1581-1587
-
-
-
10
-
-
70350697379
-
Day-90 acute ischemic stroke outcomes can be derived from early functional activity level
-
Ovbiagele, B., & Saver, J.L. (2010). Day-90 acute ischemic stroke outcomes can be derived from early functional activity level. Cerebrovasc Dis, 29(1), 50-56
-
(2010)
Cerebrovasc Dis
, vol.29
, Issue.1
, pp. 50-56
-
-
Ovbiagele, B.1
Saver, J.L.2
-
11
-
-
38149059129
-
Time spent at home poststroke: Hometime a meaningful and robust outcome measure for stroke trials
-
Quinn, T.J., Dawson, J., Lees, J.S., Chang, T.P., Walters, M.R., & Lees, K.R. (2008). Time spent at home poststroke: "Hometime" a meaningful and robust outcome measure for stroke trials. Stroke, 39(1), 231-233
-
(2008)
Stroke
, vol.39
, Issue.1
, pp. 231-233
-
-
Quinn, T.J.1
Dawson, J.2
Lees, J.S.3
Chang, T.P.4
Walters, M.R.5
Lees, K.R.6
-
12
-
-
68149180700
-
Functional outcome measures in contemporary stroke trials
-
Quinn, T.J., Dwson, J., Walters, M.R., & Lees, K.R. (2009). Functional outcome measures in contemporary stroke trials. Int J Stroke, 4(3), 200-205
-
(2009)
Int J Stroke
, vol.4
, Issue.3
, pp. 200-205
-
-
Quinn, T.J.1
Dwson, J.2
Walters, M.R.3
Lees, K.R.4
-
13
-
-
84864377256
-
Discharge destination as a surrogate for modified rankin scale defined outcomes at 3- and 12-months poststroke among stroke survivors
-
e1401
-
Qureshi, A.I., Chaudhry, S.A., Sapkota, B.L., Rodriguez, G.J., & Suri, M.F. (2012). Discharge destination as a surrogate for modified rankin scale defined outcomes at 3- and 12-months poststroke among stroke survivors. Arch Phys Med Rehabil, 93(8), 1408-1413 e1401
-
(2012)
Arch Phys Med Rehabil
, vol.93
, Issue.8
, pp. 1408-1413
-
-
Qureshi, A.I.1
Chaudhry, S.A.2
Sapkota, B.L.3
Rodriguez, G.J.4
Suri, M.F.5
-
14
-
-
33745725399
-
Thrombolysis for ischemic stroke in the United States: Data from national hospital discharge survey 1999-2001
-
discussion 647-654
-
Qureshi, A.I., Suri, M.F., Nasar, A., He, W., Kirmani, J.F., Divani, A.A., et al. (2005). Thrombolysis for ischemic stroke in the united states: Data from national hospital discharge survey 1999-2001. Neurosurgery, 57(4), 647-654; discussion 647-654
-
(2005)
Neurosurgery
, vol.57
, Issue.4
, pp. 647-654
-
-
Qureshi, A.I.1
Suri, M.F.2
Nasar, A.3
He, W.4
Kirmani, J.F.5
Divani, A.A.6
-
15
-
-
84879069684
-
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke
-
Saver, J.L., Fonarow, G.C., Smith, E.E., Reeves, M.J., Grau-Sepulveda, M.V., Pan, W., et al. (2013). Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA, 309(23), 2480-2488
-
(2013)
JAMA
, vol.309
, Issue.23
, pp. 2480-2488
-
-
Saver, J.L.1
Fonarow, G.C.2
Smith, E.E.3
Reeves, M.J.4
Grau-Sepulveda, M.V.5
Pan, W.6
|